Victor Sandor

Victor Sandor is currently an Independent Non-Executive Director at ADC Therapeutics SA since 2020, an Independent Director at Prelude Therapeutics, Inc. since 2020, an Independent Director at Kymera Therapeutics, Inc. since 2022, a Director at Istari Oncology, Inc. since 2019, and an Independent Director at AbCellera Biologics, Inc. starting in 2026.
Former roles include Independent Non-Executive Director at Merus NV from 2019 to 2025, SVP-Global Clinical Development at Incyte Corp.
from 2014 to 2019, Chief Medical Officer at Array BioPharma, Inc. from 2014 to 2019, Head-Oncology Product Development at AstraZeneca, Inc., and Chief Medical Officer-Oncology & VP at Biogen Idec, Inc. (North Carolina) from 2010 to 2014.
Education includes a doctorate from McGill University.